ESTES DANIEL 4
4 · Arcutis Biotherapeutics, Inc. · Filed Mar 3, 2020
Insider Transaction Report
Form 4
ESTES DANIEL
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-02-27+24,000→ 24,000 totalExercise: $27.61Exp: 2030-02-27→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable 100% on the earlier of the date of the next annual meeting of the Issuer's stockholders or February 27, 2021.